C16 Biosciences Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
32
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
45
C16 Biosciences General Information
Description
Developer of high performance, bio-manufactured ingredients intended to produce novel active ingredients and lipid alternatives through sustainable processes. The company offers ingredients derived from naturally occurring yeast strains processed through industrial-scale fermentation, enabling consumer packaged goods manufacturers and beauty brands to improve supply reliability, maintain product consistency, and adapt to evolving consumer preferences and regulatory requirements.
Contact Information
Website
www.c16bio.comCorporate Office
- 619 West 54th Street
- 9th Floor
- New York, NY 10019
- United States
Corporate Office
- 619 West 54th Street
- 9th Floor
- New York, NY 10019
- United States
C16 Biosciences Timeline
C16 Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Accelerator/Incubator | 01-Jan-2026 | Completed | Generating Revenue | |||
| 7. Grant | 24-Jan-2024 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series A1) | 21-Nov-2023 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 17-Oct-2023 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A) | 14-Feb-2020 | Completed | Generating Revenue | |||
| 3. Seed Round | 31-Aug-2018 | Completed | Startup | |||
| 2. Accelerator/Incubator | 21-Aug-2018 | $120K | $120K | Completed | Startup | |
| 1. Accelerator/Incubator | Completed | Startup |
C16 Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | ||||||||
| Series A-4 | ||||||||
| Series A-3 | 609,733 | $0.000100 | 6% | $2.13 | $2.13 | 1x | $2.13 | 4.54% |
| Series A-2 | 541,722 | $0.000100 | 6% | $2.84 | $2.84 | 1x | $2.84 | 4.04% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
C16 Biosciences Comparisons
Industry
Financing
Details
C16 Biosciences Competitors (3)
One of C16 Biosciences’s 3 competitors is Xylome, a Corporation company based in Madison, WI.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Xylome | Corporation | Madison, WI | ||||
| Kiverdi | Venture Capital-Backed | Pleasanton, CA | ||||
| Zero Acre | Venture Capital-Backed | San Francisco, CA |
C16 Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
C16 Biosciences Patents
C16 Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4572619-A2 | Microbial oils | Pending | 19-Aug-2022 | ||
| EP-4572619-A4 | Microbial oils | Pending | 19-Aug-2022 | ||
| US-20260053159-A1 | Microbial oils | Pending | 19-Aug-2022 | ||
| WO-2024040224-A2 | Microbial oils | Inactive | 19-Aug-2022 | ||
| WO-2024040224-A3 | Microbial oils | Inactive | 19-Aug-2022 | A23D9/007 |
C16 Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
C16 Biosciences Investors (45)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Plug and Play | Accelerator/Incubator | |||
| Gates Foundation | Not-For-Profit Venture Capital | |||
| Climate Tech Circle | Venture Capital | Minority | ||
| E12 Venture Capital | Venture Capital | Minority | ||
| Evolution VC Partners | Venture Capital | Minority |
C16 Biosciences FAQs
-
When was C16 Biosciences founded?
C16 Biosciences was founded in 2018.
-
Where is C16 Biosciences headquartered?
C16 Biosciences is headquartered in New York, NY.
-
What is the size of C16 Biosciences?
C16 Biosciences has 32 total employees.
-
What industry is C16 Biosciences in?
C16 Biosciences’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is C16 Biosciences a private or public company?
C16 Biosciences is a Private company.
-
What is C16 Biosciences’s current revenue?
The current revenue for C16 Biosciences is .
-
How much funding has C16 Biosciences raised over time?
C16 Biosciences has raised $30.1M.
-
Who are C16 Biosciences’s investors?
Plug and Play, Gates Foundation, Climate Tech Circle, E12 Venture Capital, and Evolution VC Partners are 5 of 45 investors who have invested in C16 Biosciences.
-
Who are C16 Biosciences’s competitors?
Xylome, Kiverdi, and Zero Acre are competitors of C16 Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
